The Coming Talent Crisis in Life Sciences

June 29, 2026

Arcus’ HIF-2a Inhibitor Shows Positive Response Rate in Study

October 29, 2024

Corxel Ready to Make Waves Worldwide After Positive Oral GLP-1 Phase 2 Results

July 1, 2026

Must Read

FDA Expands Casgevy Approval to Children Aged 2 With Sickle Cell Disease and Beta Thalassemia

July 9, 2026

In its biggest-ever transaction, Vertex pays $10 billion to buy endocrine disease expert Crinetics

July 9, 2026

Phase 3 KRYSTAL-10 Study Fails to Meet Primary Endpoints for Krazati in Metastatic Colorectal Cancer

July 9, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Phase 3 KRYSTAL-10 Study Fails to Meet Primary Endpoints for Krazati in Metastatic Colorectal Cancer

Kailera and Hengrui Report Phase 3 Results for Oral GLP-1 Drug in Obesity and Type 2 Diabetes

Phase 3 NSCLC study for Pfizer’s first novel ADC from the acquisition of Seagen fails

BridgeBio Advances Attruby Launch and Three Late-Stage Drug Programs as It Secures New Investment

In its biggest-ever transaction, Vertex pays $10 billion to buy endocrine disease expert Crinetics

Orca Bio Gets FDA Green Light For Tregzi; IPO a Real Possibility

Ipsen to Acquire Memo and Phase 2 BKPyV Antibody Potravitug in Deal Worth Up to €700 Million

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Top 10 Reasons Precision Medicine Requires Better Data Integration

Why Pharma Supply Chains Need a Resilience-First Strategy

Top 10 Real-World Use Cases for AI in Clinical Development

Why Medical Affairs Teams Need New Skills for the Next Decade

Editorial Team

Potentially tough road for BMS as immuno-oncology pricing war looms

Editor Picks

The Coming Talent Crisis in Life Sciences

Arcus’ HIF-2a Inhibitor Shows Positive Response Rate in Study

Corxel Ready to Make Waves Worldwide After Positive Oral GLP-1 Phase 2 Results

Must Read

FDA Expands Casgevy Approval to Children Aged 2 With Sickle Cell Disease and Beta Thalassemia

In its biggest-ever transaction, Vertex pays $10 billion to buy endocrine disease expert Crinetics

Phase 3 KRYSTAL-10 Study Fails to Meet Primary Endpoints for Krazati in Metastatic Colorectal Cancer

Hot Topics

About Us

Follow Us